MassMutual Private Wealth & Trust’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.63K Sell
224
-95
-30% -$2.59K ﹤0.01% 1575
2026
Q2
$8.61K Hold
319
– – ﹤0.01% 1467
2026
Q1
$8.64K Hold
319
– – ﹤0.01% 1425
2025
Q4
$11.6K Hold
319
– – ﹤0.01% 1318
2025
Q3
$12.1K Hold
319
– – ﹤0.01% 1315
2025
Q2
$4.32K Hold
319
– – ﹤0.01% 1692
2025
Q1
$5.07K Hold
319
– – ﹤0.01% 1599
2024
Q4
$3.93K Hold
319
– – ﹤0.01% 1616
2024
Q3
$3.86K Hold
319
– – ﹤0.01% 1458
2024
Q2
$3.73K Hold
319
– – ﹤0.01% 1413
2024
Q1
$4.12K Hold
319
– – ﹤0.01% 1331
2023
Q4
$2.74K Buy
+319
New +$2.5K ﹤0.01% 1407

Other funds holding MLYS

MassMutual Private Wealth & Trust's MLYS Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Mineralys Therapeutics (MLYS) stake by 30% in Q3 2026, selling an estimated $2.59K and leaving 224 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

MassMutual Private Wealth & Trust first reported a position in MLYS in Q4 2023 and has held it in 12 quarters since. The position peaked at $12.1K in Q3 2025. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • MassMutual Private Wealth & Trust held 224 shares of Mineralys Therapeutics worth $5.63K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 95 Mineralys Therapeutics shares in Q3 2026, an estimated $2.59K.
  • Mineralys Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1575 holding.
  • MassMutual Private Wealth & Trust first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • MassMutual Private Wealth & Trust's Mineralys Therapeutics position peaked at $12.1K in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.